Table 3. Pattern of false negative HMLN involvement (17 of 129 patients).

Case	Lobar distribution	Concurrent disease	Histopathological type	Tumor size(cm)	SUVmax of tomor	SUVmax of node	Pathological N(+) station
1	RUL	None	Squamous cell carcinoma	2.8	7.3	2.4	10
2	RUL	None	Adenosqumaous carcinoma	2.4	12.8	0	2R,4R
3	RUL	None	Adenocarcinoma	1.4	7.0	0	10
4	RUL	None	Adenocarcinoma	2.3	6.0	2.4	10
5	RUL	Tuberculosis	Adenocarcinoma	1.6	3.0	0	10
6	RML	None	Squamous cell carcinoma	3.5	8.8	0	10
7	RLL	None	Adenocarcinoma	4.0	12.0	2.5	2R,4R,7,10
8	RLL	Pneumonia	Adenocarcinoma	2.1	3.3	0	10
9	LUL	diabetes	Adenosqumaous carcinoma	3.0	5.4	0	4L,6,10
10	LUL	diabetes	Adenocarcinoma	3.6	4.4	1.7	6,10
11	LUL	None	Adenocarcinoma	2.8	10.2	2.5	4L,5,6,7,10
12	LUL	diabetes	Adenosqumaous carcinoma	2.5	5.4	0	4L,6,10
13	LLL	diabetes	Adenocarcinoma	3.9	4.7	0	7
14	LLL	None	Adenocarcinoma	3.1	4.5	0	7
15	LLL	None	Large cell carcinoma	3.4	5.3	0	4L,6,7,10
16	LLL	diabetes	Squamous cell carcinoma	4.4	7.6	2.2	4L,6,7,9
17	LLL	Tuberculosis	Hemangioendothelioma	1.5	2.4	0	5,7,10